Esperion to Participate in January Investor Meetings
December 13 2022 - 8:00AM
Esperion (NASDAQ: ESPR) announced today that the Company plans to
present at the J.P. Morgan 41st Annual Healthcare Conference as
well as the LifeSci Partners 12th Annual Corporate Access Event.
Both in-person events are taking place January 9-11th, 2023 in San
Francisco, California.
J.P. Morgan 41st
Annual Healthcare ConferenceSheldon Koenig, CEO,
will be making a corporate presentation and hosting 1x1
institutional investor meetings.
Date/Time: January 11th, 2023, 1:30pm
PTLocation: The Westin St. Francis Hotel in San
Francisco; Georgian RoomClick here to access the webcast.
LifeSci Partners 12th
Annual Corporate Access EventSheldon Koenig, CEO,
Ben Halladay, CFO, and JoAnne Foody, CMO, will be hosting 1x1
institutional investor meetings.
Date/Time: January 9-10th,
2023Location: Beacon Grand Hotel in San
FranciscoTo schedule a meeting on the online system managed by
LifeSci Partners, please click here to register for the
conference.
Esperion TherapeuticsEsperion works hard to
make our medicines easy to get, easy to take, and easy to have. We
discover, develop, and commercialize innovative medicines and
combinations to lower cholesterol, especially for patients whose
needs aren’t being met by the status quo. Our entrepreneurial team
of industry leaders is inclusive, passionate and resourceful. We
are singularly focused on managing cholesterol so you can improve
your health easily. For more information, please visit
www.esperion.com and follow us on Twitter at
www.twitter.com/EsperionInc.
Contact:Esperion Corporate
Communicationscorporateteam@esperion.com
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jul 2023 to Jul 2024